Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District

NCT03001570 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma of the Head and Neck

Interventions

DRUG: Cetuximab plus Radiotherapy

Sponsor

European Institute of Oncology